S S Kline, C C Harrell. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AgedAnticoagulants/administration & dosageAnticoagulants/adverse effectsDrug InteractionsDrug MonitoringDrug Therapy, CombinationEnzyme Inhibitors/administration & dosageEnzyme Inhibitors/adverse effectsFatty Acids, Monounsaturated/administration & dosageFatty Acids, Monounsaturated/adverse effectsFemaleFluvastatinHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIndoles/administration & dosageIndoles/adverse effectsMaleMiddle AgedWarfarin/administration & dosageWarfarin/adverse effects
Substances: See more » AnticoagulantsEnzyme InhibitorsFatty Acids, MonounsaturatedHydroxymethylglutaryl-CoA Reductase InhibitorsIndolesFluvastatinWarfarin
Year: 1997 PMID: 9184730 DOI: 10.1177/106002809703100625
Source DB: PubMed Journal: Ann Pharmacother ISSN: 1060-0280 Impact factor: 3.154